COMMUNIQUÉS West-GlobeNewswire

Helius Medical Technologies Submits Request for FDA 510(k) Clearance of the PoNS™ Device
04/09/2018
NEWTOWN, Pa., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that the [...]
Aleafia Secures Sales Licence from Health Canada
04/09/2018
TORONTO, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF) (“Aleafia“) or (the “Company“), one of Canada’s leading, vertically integrated medical cannabis companies with a unique patient- [...]
Recro Pharma Provides Regulatory Update for IV Meloxicam
04/09/2018
Company Anticipates NDA Resubmission by the End of September 2018 MALVERN, Pa., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on [...]
Transactions in relation to share buyback program
04/09/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
HealthLynked Corp. Creates Data Archive with over 15,000 Medical Articles Covering a Wide Range of Medical Topics for Use in its AI Architecture
04/09/2018
NAPLES, Fla., Sept. 04, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB: HLYK) today announced that it has created a unique database of over 15,000 medical publications and research articles that it plans to use for [...]
Rule 2.9 Announcement
04/09/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 4 September 2018 [...]
Achaogen Highlights Multiple Plazomicin Presentations at ESCMID/ASM 2018 Conference
04/09/2018
SOUTH SAN FRANCISCO, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative [...]
ASLAN Pharmaceuticals to Present at HC Wainwright 20th Annual Global Investment Conference
04/09/2018
SINGAPORE, Sept. 04, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN, TPEx:6497), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in [...]
BIOPHYTIS Provides Enrollment Update in Its Phase 2b SARA-OBS and SARA-INT Studies of Sarconeos in Sarcopenia
04/09/2018
Over 200 patients recruited in the SARA-OBS study with the majority of patients enrolled from the U.S. and Belgium 60 patients ready to enter the SARA-INT trial PARIS, Sept. 04, 2018 (GLOBE NEWSWIRE) -- BIOPHYTIS ( [...]
Curetis' Subsidiary Ares Genetics Initiates Development of AI-Powered Infectious Disease Test
04/09/2018
Curetis' Subsidiary Ares Genetics Initiates Development of AI-Powered Infectious Disease Test ARESupa test aims at broad detection of microbial infections employing next-generation sequencing and artificial intelligence [...]
Santhera Announces Financial Results for the First Half-Year 2018 and Updates on Operational Progress and Growth Strategy
04/09/2018
A conference call will be held today at 13:00 CEST, 12:00 BST, 07:00 EDT. Details are at the end of this statement. Pratteln, Switzerland, September 4, 2018 - Santhera Pharmaceuticals (SIX: SANN) reports first half-year [...]
Probiodrug Appoints Dr. Michael Schaeffer as Executive Vice President of Business and Strategy
04/09/2018
Probiodrug Appoints Dr. Michael Schaeffer as Executive Vice President of Business and Strategy HALLE (SAALE), Germany, 04 September, 2018: Probiodrug AG (Euronext Amsterdam: PBD), a clinical stage biopharmaceutical [...]
Inovio and Korean Partner Dose 1st Subject In Trial to Develop World’s First Vaccine to Prevent Hepatitis C Infection
04/09/2018
While new therapies have made hepatitis C a curable infection, no preventive vaccine has ever been approved PLYMOUTH MEETING, Pa., and SEOUL, Korea, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. ( [...]
Addex’s Selective mGlu2 PAM ADX71149 Shows Promise in Treating Severe Panic Disorders and PTSD
04/09/2018
Preclinical and Adhoc Clinical Data Published in Molecular Psychiatry Geneva, Switzerland, 4 September 2018 – Addex Therapeutics (SIX: ADXN), a leading company pioneering allosteric modulation-based drug discovery and [...]
Ossur Hf : Transactions in relation to share buyback program
03/09/2018
Announcement no. 53/2018 3 September 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the share [...]
Nicox: Number of voting rights as of August 31, 2018
03/09/2018
Nicox SA Société anonyme with a registered capital of € 29,588,510 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On September 3, 2018, MONTHLY PUBLICATION OF THE [...]
Nicox : Nombre total de droits au 31 août 2018
03/09/2018
Nicox SA Société anonyme au capital de 29 588 510 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 3 septembre 2018, PUBLICATION MENSUELLE DU NOMBRE D' [...]
Nicox confirme son éligibilté au PEA-PME
03/09/2018
Communiqué de presse Nicox confirme son éligibilité au PEA-PME ................................................. 3 septembre 2018 Sophia Antipolis, France / Research Triangle Park, NC, Etats-Unis Nicox SA (Euronext [...]
ThromboGenics becomes "Oxurion"
03/09/2018
Press release Shareholders approve new name which better reflects the Company's ambition to deliver best in class therapies for back of the eye disorders Leuven, Belgium, 3 September 2018 - ThromboGenics NV (Euronext [...]

Pages